BIOA
BioAge Labs, Inc.
+0.17 (+2.19%)7.92USD239K成交股數364M市值–本益比(近四季)35.1股價營收比+1.6%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 1.6M · 1 |
| 其中 10b5-1 計畫賣出 | 2 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 1.7M |
| 近 180 天 淨額 | −1.7M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 4.3K | 10.85 | 47K | 4.3K | SEC |
| 2026-06-30 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 4.0K | 8.39 | 34K | 8.3K | SEC |
| 2026-06-30 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 4.1K | 4.30 | 17K | 12.4K | SEC |
| 2026-06-30 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 7.9K | 4.38 | 34K | 20.2K | SEC |
| 2026-06-30 | 07-01 | Barton Shane | Principal Accounting Officer | S 公開市場賣出(10b5-1) | 20.2K | 25.19 | 509K | 0 | SEC |
| 2026-06-29 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 7.3K | 8.39 | 61K | 19.2K | SEC |
| 2026-06-29 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 9.0K | 4.30 | 39K | 28.2K | SEC |
| 2026-06-29 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 9.3K | 10.85 | 101K | 11.9K | SEC |
| 2026-06-29 | 07-01 | Barton Shane | Principal Accounting Officer | M 選擇權執行 | 14.2K | 4.38 | 62K | 42.4K | SEC |
| 2026-06-29 | 07-01 | Barton Shane | Principal Accounting Officer | S 公開市場賣出(10b5-1) | 42.4K | 25.21 | 1.1M | 0 | SEC |
| 2026-04-23 | 04-24 | GOLDSTEIN DOV A MD | Chief Financial Officer | M 選擇權執行 | 3.5K | 4.38 | 16K | 36.6K | SEC |
| 2026-04-01 | 04-03 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 5.4K | 4.11 | 22K | 5.4K | SEC |
| 2026-04-01 | 04-03 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 3.4K | 6.57 | 22K | 8.8K | SEC |
| 2026-04-01 | 04-03 | RUBIN PAUL D | Chief Medical Officer | S 公開市場賣出(10b5-1) | 8.8K | 17.81 | 157K | 0 | SEC |
| 2026-03-02 | 03-03 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 2.0K | 6.57 | 13K | 7.4K | SEC |
| 2026-03-02 | 03-03 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 5.4K | 4.11 | 22K | 5.4K | SEC |
| 2026-03-02 | 03-03 | RUBIN PAUL D | Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.4K | 20.30 | 151K | 0 | SEC |
| 2026-03-01 | 03-03 | GOLDSTEIN DOV A MD | Chief Financial Officer | M 選擇權執行 | 3.5K | 4.38 | 16K | 33.0K | SEC |
| 2026-02-02 | 02-03 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 2.0K | 6.57 | 13K | 7.4K | SEC |
| 2026-02-02 | 02-03 | RUBIN PAUL D | Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.4K | 18.75 | 139K | 0 | SEC |
| 2026-02-02 | 02-03 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 5.4K | 4.11 | 22K | 5.4K | SEC |
| 2026-02-01 | 02-03 | GOLDSTEIN DOV A MD | Chief Financial Officer | M 選擇權執行 | 3.5K | 4.38 | 16K | 29.5K | SEC |
| 2026-01-16 | 01-21 | GOLDSTEIN DOV A MD | Chief Financial Officer | M 選擇權執行 | 3.5K | 4.38 | 16K | 25.9K | SEC |
| 2026-01-13 | 01-15 | GOLDSTEIN DOV A MD | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.9K | 21.08 | 41K | 22.4K | SEC |
| 2026-01-13 | 01-15 | Fortney Kristen | Chief Executive Officer | S 公開市場賣出(10b5-1) | 233K | 18.12 | 4.2M | 977K | SEC |
| 2026-01-13 | 01-15 | GOLDSTEIN DOV A MD | Chief Financial Officer | M 選擇權執行 | 27.0K | 8.39 | 227K | 49.4K | SEC |
| 2026-01-13 | 01-15 | GOLDSTEIN DOV A MD | Chief Financial Officer | S 公開市場賣出(10b5-1) | 9.0K | 18.43 | 165K | 40.4K | SEC |
| 2026-01-13 | 01-15 | GOLDSTEIN DOV A MD | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.4K | 19.45 | 86K | 36.0K | SEC |
| 2026-01-13 | 01-15 | GOLDSTEIN DOV A MD | Chief Financial Officer | S 公開市場賣出(10b5-1) | 11.7K | 20.54 | 240K | 24.3K | SEC |
| 2026-01-02 | 01-06 | RUBIN PAUL D | Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.4K | 12.85 | 96K | 0 | SEC |
| 2026-01-02 | 01-06 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 5.4K | 4.11 | 22K | 5.4K | SEC |
| 2026-01-02 | 01-06 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 2.0K | 6.57 | 13K | 7.4K | SEC |
| 2025-12-09 | 12-11 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 18.0K | 6.57 | 118K | 18.0K | SEC |
| 2025-12-09 | 12-11 | RUBIN PAUL D | Chief Medical Officer | S 公開市場賣出(10b5-1) | 18.0K | 12.00 | 216K | 0 | SEC |
| 2025-12-04 | 12-05 | RUBIN PAUL D | Chief Medical Officer | M 選擇權執行 | 68.9K | 4.11 | 283K | 68.9K | SEC |
| 2025-12-04 | 12-05 | RUBIN PAUL D | Chief Medical Officer | S 公開市場賣出(10b5-1) | 68.9K | 10.19 | 702K | 0 | SEC |
| 2024-10-03 | 10-03 | Pande Vijay Satyanand | Director | P 公開市場買進 | 25.3K | 19.90 | 504K | 1.1M | SEC |
| 2024-10-02 | 10-03 | Pande Vijay Satyanand | Director | P 公開市場買進 | 67.1K | 19.73 | 1.3M | 1.1M | SEC |
| 2024-10-01 | 10-03 | Pande Vijay Satyanand | Director | P 公開市場買進 | 127K | 19.73 | 2.5M | 1.0M | SEC |
| 2024-09-27 | 03-10 | Hemrajani Rekha | Director | P 公開市場買進 | 3.0K | 18.00 | 54K | 3.0K | SEC |
| 2024-09-27 | 03-10 | Barton Shane | Principal Accounting Officer | P 公開市場買進 | 2.6K | 18.00 | 47K | 2.6K | SEC |
| 2024-09-27 | 10-01 | Cormorant Private Healthcare Fund V LP | Other | C 轉換 | 1.2M | – | – | 1.2M | SEC |
| 2024-09-27 | 10-01 | Cormorant Asset Management, LP | Other | C 轉換 | 1.2M | – | – | 1.2M | SEC |
| 2024-09-27 | 10-01 | Cormorant Asset Management, LP | Other | P 公開市場買進 | 450K | 18.00 | 8.1M | 1.6M | SEC |
| 2024-09-27 | 10-01 | Chen Bihua | Other | C 轉換 | 1.2M | – | – | 1.2M | SEC |
| 2024-09-27 | 10-01 | Chen Bihua | Other | P 公開市場買進 | 450K | 18.00 | 8.1M | 1.6M | SEC |
| 2024-09-27 | 10-01 | Cormorant Private Healthcare Fund IV LP | Other | C 轉換 | 1.2M | – | – | 1.2M | SEC |
| 2024-09-27 | 10-01 | Cormorant Private Healthcare Fund IV LP | Other | P 公開市場買進 | 450K | 18.00 | 8.1M | 1.6M | SEC |
| 2024-09-27 | 10-01 | Cormorant Private Healthcare Fund V LP | Other | P 公開市場買進 | 450K | 18.00 | 8.1M | 1.6M | SEC |
| 2024-09-27 | 09-27 | HEALY JAMES | Director | C 轉換 | 1.6M | – | – | 1.6M | SEC |
| 2024-09-27 | 09-27 | HEALY JAMES | Director | P 公開市場買進 | 589K | 18.00 | 10.6M | 2.2M | SEC |
| 2024-09-27 | 09-27 | HEALY JAMES | Director | P 公開市場買進 | 11.1K | 18.00 | 200K | 11.1K | SEC |
| 2024-09-27 | 09-27 | HEALY JAMES | Director | P 公開市場買進 | 18.4K | 18.00 | 330K | 18.4K | SEC |
| 2024-09-27 | 09-27 | HEALY JAMES | Director | P 公開市場買進 | 21.8K | 18.00 | 393K | 21.8K | SEC |
| 2024-09-27 | 09-27 | HEALY JAMES | Director | P 公開市場買進 | 26.5K | 18.00 | 477K | 26.5K | SEC |
| 2024-09-27 | 09-27 | ENRIGHT PATRICK G | Director | C 轉換 | 1.3M | – | – | 1.3M | SEC |
| 2024-09-27 | 09-27 | ENRIGHT PATRICK G | Director | P 公開市場買進 | 400K | 18.00 | 7.2M | 1.7M | SEC |
| 2024-09-27 | 09-27 | Pande Vijay Satyanand | Director | C 轉換 | 856K | – | – | 856K | SEC |
| 2024-09-27 | 09-27 | Pande Vijay Satyanand | Director | C 轉換 | 413K | – | – | 1.3M | SEC |
| 2024-09-27 | 09-27 | Pande Vijay Satyanand | Director | C 轉換 | 190K | – | – | 190K | SEC |
| 2024-09-27 | 09-27 | Pande Vijay Satyanand | Director | C 轉換 | 655K | – | – | 655K | SEC |
| 2024-09-27 | 09-27 | Pande Vijay Satyanand | Director | P 公開市場買進 | 900K | 18.00 | 16.2M | 900K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 3.2M | 79.2M | 新進 | 新進 |
| BlackRock, Inc. | 2.8M | 69.8M | 新進 | 新進 |
| Cormorant Asset Management, LP | 2.4M | 58.6M | 新進 | 新進 |
| Sofinnova Investments, Inc. | 2.3M | 56.2M | 新進 | 新進 |
| Jupiter Topco LLC | 2.1M | 52.6M | 新進 | 新進 |
| Octagon Capital Advisors LP | 1.7M | 42.8M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 1.7M | 41.0M | 新進 | 新進 |
| MPM BIOIMPACT LLC | 1.7M | 40.9M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | 37.8M | 新進 | 新進 |
| Polar Capital Holdings Plc | 1.1M | 26.3M | 新進 | 新進 |
| BRAIDWELL LP | 1.0M | 25.3M | 新進 | 新進 |
| STATE STREET CORP | 1.0M | 25.0M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.0M | 24.6M | 新進 | 新進 |
| Sands Capital Alternatives, LLC | 786K | 19.3M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 752K | 18.4M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 743K | 18.2M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 703K | 17.2M | 新進 | 新進 |
| Pivotal bioVenture Partners Investment Advisor LLC | 653K | 16.0M | 新進 | 新進 |
| COSMIC MANAGEMENT, LLC | 502K | 12.3M | 新進 | 新進 |
| STEMPOINT CAPITAL LP | 464K | 11.4M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 410K | 10.1M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 394K | 9.7M | 新進 | 新進 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 377K | 9.2M | 新進 | 新進 |
| Walleye Capital LLC | 354K | 8.7M | 新進 | 新進 |
| Nuveen, LLC | 349K | 8.6M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 151 +7 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 151 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 37.7M · 82.2% |
| 合計季末市值 | 918M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.7M |
|---|---|
| 與上期比 | +22.8% |
| 佔流通股數 | 5.93% |
| 日均成交量 | 577K |
| 回補天數 | 4.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.7M | +22.8% | 5.93% | 577K | 4.7 |
| 2026-08-14 | 2.2M | -13.6% | 4.83% | 1.2M | 1.9 |
| 2026-07-31 | 2.6M | +4.7% | 5.59% | 1.4M | 1.9 |
| 2026-07-15 | 2.5M | -34.5% | 5.34% | 540K | 4.5 |
| 2026-06-30 | 3.7M | +87.9% | 8.16% | 933K | 4.0 |
| 2026-06-15 | 2.0M | +11.3% | 4.34% | 383K | 5.2 |
| 2026-05-29 | 1.8M | +4.8% | 3.90% | 474K | 3.8 |
| 2026-05-15 | 1.7M | -9.3% | 3.72% | 372K | 4.6 |
| 2026-04-30 | 1.9M | +8.0% | 4.11% | 430K | 4.4 |
| 2026-04-15 | 1.7M | +11.9% | 3.80% | 333K | 5.2 |
| 2026-03-31 | 1.6M | +15.5% | 3.40% | 686K | 2.3 |
| 2026-03-13 | 1.4M | +5.8% | 2.94% | 520K | 2.6 |
| 2026-02-27 | 1.3M | -4.9% | 2.78% | 472K | 2.7 |
| 2026-02-13 | 1.3M | +47.6% | 2.92% | 644K | 2.1 |
| 2026-01-30 | 909K | -16.3% | 1.98% | 920K | 1.0 |
| 2026-01-15 | 1.1M | +82.2% | 2.37% | 1.1M | 1.0 |
| 2025-12-31 | 596K | +6.8% | 1.30% | 317K | 1.9 |
| 2025-12-15 | 558K | +10.9% | 1.22% | 592K | 1.0 |
| 2025-11-28 | 503K | +17.5% | 1.10% | 230K | 2.2 |
| 2025-11-14 | 428K | -7.6% | 0.93% | 286K | 1.5 |
| 2025-10-31 | 464K | -33.1% | 1.01% | 903K | 1.0 |
| 2025-10-15 | 693K | -72.2% | 1.51% | 185K | 3.8 |
| 2025-09-30 | 2.5M | +6.7% | 5.43% | 206K | 12.1 |
| 2025-09-15 | 2.3M | +0.1% | 5.09% | 176K | 13.3 |
| 2025-08-29 | 2.3M | -2.8% | 5.09% | 173K | 13.5 |
| 2025-08-15 | 2.4M | +0.7% | 5.23% | 103K | 23.2 |